Company Directory > Biotech > Samarth Life Sciences Pvt. Ltd.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Samarth Life Sciences Pvt. Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Samarth Life Sciences is an Indian pharmaceutical company established in 1963, specializing in the research, development, manufacturing, and marketing of critical care and specialty drugs. The company operates globally, exporting products to over 70 countries, and maintains a strong focus on therapeutic areas including anesthesiology, oncology, gastroenterology, and critical care. The company operates multiple manufacturing facilities in India, including units in Baddi (Himachal Pradesh) and Tumkur (Karnataka), which are compliant with international standards. Samarth has been recognized for its contributions to the pharmaceutical sector, including awards for being an emerging company and for its advancements in biotech capabilities.
CLASSIFICATION
Company Type:Biotech
Industry:Pharmaceuticals
Sub-Industry:Critical Care, Specialty Pharma
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$75M-$80M
Founded:1963
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:Cipla, Macleods Pharmaceuticals, Gufic Group
LEADERSHIP
Key Executives:
Gunwantlal Shah - Founder
B Ghelani - CEO
Scientific Founders:Gunwantlal Shah
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Samarth Life Sciences Pvt. Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.